Parkin , a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
In an effort to identify tumor suppressor gene(s) associated with the frequent loss of heterozygosity observed on chromosome 6q25–q27, we constructed a contig derived from the sequences of bacterial artificial chromosome/P1 bacteriophage artificial chromosome clones defined by the genetic interval D6S1581–D6S1579–D6S305–D6S1599–D6S1008. Sequence analysis of this contig found it to contain eight known genes, including the complete genomic structure of the Parkin gene. Loss of heterozygosity (LOH) analysis of 40 malignant breast and ovarian tumors identified a common minimal region of loss, including the markers D6S305 (50%) and D6S1599 (32%). Both loci exhibited the highest frequencies of LOH in this study and are each located within the Parkin genomic structure. Whereas mutation analysis revealed no missense substitutions, expression of the Parkin gene appeared to be down-regulated or absent in the tumor biopsies and tumor cell lines examined. In addition, the identification of two truncating deletions in 3 of 20 ovarian tumor samples, as well as homozygous deletion of exon 2 in the lung adenocarcinoma cell lines Calu-3 and H-1573, supports the hypothesis that hemizygous or homozygous deletions are responsible for the abnormal expression of Parkin in these samples. These data suggest that the LOH observed at chromosome 6q25–q26 may contribute to the initiation and/or progression of cancer by inactivating or reducing the expression of the Parkin gene. Because Parkin maps to FRA6E , one of the most active common fragile sites in the human genome, it represents another example of a large tumor suppressor gene, like FHIT and WWOX , located at a common fragile site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
Gessler, M., Poustka, A., Cavenee, W., Neve, R. L., Orkin, S. H., & Bruns, G. A. P. (1990) · Nature · doi:10.1038/343774a0 · Cited by 1,292
Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81034-x · Cited by 990
Self-citationZhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Imai, Y., Soda, M., & Takahashi, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000447200 · Cited by 766
Antioncogenes and human cancer.
Knudson, A. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10914 · Cited by 762
Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K.-I., & Takahashi, R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00583-x · Cited by 473
Bednarek, A. K., Laflin, K. J., DANIEL, R. L., Liao, Q., Hawkins, K. A., & Aldaz, C. M. (2000) · PubMed · Cited by 472
The MDM2 RING-finger domain is required to promote p53 nuclear export
Geyer, R. K., Yu, Z. K., & Maki, C. G. (2000) · Nature Cell Biology · doi:10.1038/35023507 · Cited by 361
Nikolaev, A. Y., Li, M., Puskas, N., Qin, J., & Gu, W. (2003) · Cell · doi:10.1016/s0092-8674(02)01255-2 · Cited by 356
Benedict, W. F., Murphree, A. L., Banerjee, A., Spina, C. A., Sparkes, M. C., & Sparkes, R. S. (1983) · Science · doi:10.1126/science.6336308 · Cited by 339
An intact HDM2 RING-finger domain is required for nuclear exclusion of p53
Boyd, S. D., Tsai, K. Y., & Jacks, T. (2000) · Nature Cell Biology · doi:10.1038/35023500 · Cited by 334
Tumorigenicity in Human Melanoma Cell Lines Controlled by Introduction of Human Chromosome 6
Trent, J. M., Stanbridge, E. J., McBride, H. L., Meese, E. U., Casey, G., Araujo, D. E., Witkowski, C. M., & Nagle, R. B. (1990) · Science · doi:10.1126/science.2300817 · Cited by 326
Molecular cloning and characterization of a full‐length cDNA clone for human plasminogen
Forsgren, M., Råden, B., Israelsson, M., Larsson, K., & Hedén, L.-O. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81501-6 · Cited by 229
Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.
Millikin, D., Meese, E. U., Vogelstein, B., Witkowski, C. M., & Trent, J. M. (1991) · PubMed · Cited by 227
WWOX : A candidate tumor suppressor gene involved in multiple tumor types
Paige, A. J. W., Taylor, K. J., Taylor, C., Hillier, S. G., Farrington, S., Scott, D., Porteous, D. J., Smyth, J. F., Gabra, H., & Watson, J. E. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191175898 · Cited by 219
Hinds, P. W., & Weinberg, R. A. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90102-3 · Cited by 207
Souza, A. T. D., Hankins, G. R., Washington, M. K., Fine, R. L., Orton, T. C., & Jirtle, R. L. (1995) · PubMed · Cited by 187
Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma
Gaïdano, G., Hauptschein, R. S., Parsa, N., Offit, K., Rao, P., Lenoir, G., Knowles, D., CHAGANTI, R. S. K., & Dalla‐Favera, R. (1992) · Blood · doi:10.1182/blood.v80.7.1781.1781 · Cited by 187
Regulation of MTK1/MEKK4 Kinase Activity by Its N-Terminal Autoinhibitory Domain and GADD45 Binding
Mita, H., Tsutsui, J., Takekawa, M., Witten, E. A., & Saito, H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4544-4555.2002 · Cited by 154
Parkin and Parkinsonʼs disease
Mizuno, Y., Hattori, N., Mori, H., Suzuki, T., & Tanaka, K. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00008 · Cited by 152
Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.
Morita, R., Saito, S., Ishikawa, J., Ogawa, O., Yoshida, O., Yamakawa, K., & Nakamura, Y. (1991) · PubMed · Cited by 149
Cancer-specific chromosome alterations in the constitutive fragile region FRA3 B
Mimori, K., Druck, T., Inoue, H., Alder, H., Berk, L., Mori, M., Huebner, K., & Croce, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7456 · Cited by 125
Self-citationSequence of the FRA3B common fragile region: Implications for the mechanism of FHIT deletion
Inoue, H., Ishii, H., Alder, H., Snyder, E. E., Druck, T., Huebner, K., & Croce, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14584 · Cited by 121
Self-citationM6P/IGF2R is mutated in squamous cell carcinoma of the lung
Kong, F., Anscher, M. S., Washington, M. K., Killian, J. K., & Jirtle, R. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203437 · Cited by 108
Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia
Hayashi, Y., Raimondi, S. C., Look, A. T., Behm, F., Kitchingman, G. R., Pui, C., Rivera, G. K., & Williams, D. (1990) · Blood · doi:10.1182/blood.v76.8.1626.1626 · Cited by 105
Enhancement of PCR amplification yield and specificity using AmpliTaq Gold DNA polymerase.
Moretti, T., Koons, B. W., & Budowle, B. (1998) · PubMed · Cited by 99
Common fragile sites and cancer (review).
Smith, D. I., Huang, H., & Wang, L. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.1.187 · Cited by 74
The two human organic cation transporter genes SLC22A1 and SLC22A2 are located on chromosome 6q26
Koehler, M. R., Wissinger, B., Gorboulev, V., Koepsell, H., & Schmid, M. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000134720 · Cited by 74
Sheng, Z., Marchetti, A., Buttitta, F., Champeme, M.-H., Campani, D., Bistocchi, M., Lidereau, R., & Callahan, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.27 · Cited by 71
Definition of a commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27.
Saito, H., Sirahama, S., Matsushima, M., Suzuki, M., Sagae, S., Kudo, R., Saito, J., Noda, K., & Nakamura, Y. (1996) · PubMed · Cited by 62
The Genomic Structure and Promoter Region of the Human Parkin Gene
Asakawa, S., Tsunematsu, K., Takayanagi, A., Sasaki, T., Shimizu, A., Shintani, A., Kawasaki, K., Mungall, A. J. J., Beck, S., Minoshima, S., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5490 · Cited by 47
Gualandi, F., Morelli, M. C., Pavan, J. V., Rimessi, P., Sensi, A., Bonfatti, A., Gruppioni, R., Possati, L., Stanbridge, E. J., & Barbanti‐Brodano, G. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870100202 · Cited by 36
Tibiletti, M. G., Trubia, M., Ponti, E., Sessa, L., Acquati, F., Furlan, D., Bernasconi, B., Fichera, M., Mihalich, A., Ziegler, A., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201654 · Cited by 31
Cited by
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Self-citationYoule, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Deconvoluting the context-dependent role for autophagy in cancer
White, E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3262 · Cited by 1,704
Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging
Green, D. R., Galluzzi, L., & Kroemer, G. (2011) · Science · doi:10.1126/science.1201940 · Cited by 1,245
Metadata
- Authors
- Cesari, R., Martin, E. S., Calin, G. A., Pentimalli, F., Bichi, R., McAdams, H., Trapasso, F., Drusco, A., Shimizu, M., Masciullo, V., d'Andrilli, G., Scambia, G., Picchio, M. C., Alder, H., Godwin, A. K., & Croce, C. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-04-28
- Volume
- 100
- Issue
- 10
- Pages
- 5956-5961
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2008025085
- Cited by
- 314
- References
- 40
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.